Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study

This letter to the editor reports on the use of Abacavir from a pilot study conducted between February 2004 to August 2006 at King Edward VIII Hospital in Durban South Africa. The study included thirty antiretroviral therapy (ART) naive children aged between 2 and 12 years with vertically transmitted HIV-1 infection to assess the use of structured treatment interruptions.